Aortic insufficiency stages: Difference between revisions

Jump to navigation Jump to search
Line 24: Line 24:
|-
|-


| style="background: #4479BA; color: #F8F8FF"|A
| style="background: #4479BA; color: #F8F8FF"|'''A'''
| At risk of [[AR]]
| At risk of [[AR]]
| • Bicuspid valve <br>  • Valve [[sclerosis]] <br>  • History of [[rheumatic fever]] <br>  • [[Infective endocarditis]]
| • Bicuspid valve <br>  • Valve [[sclerosis]] <br>  • History of [[rheumatic fever]] <br>  • [[Infective endocarditis]]
Line 32: Line 32:


|-
|-
| style="background: #4479BA; color: #F8F8FF"|B
| style="background: #4479BA; color: #F8F8FF"|'''B'''
| Progressive [[AR]]
| Progressive [[AR]]
| • Mild-to-moderate calcification  <br> • Rheumatic valve changes <br> •  Dilatation of aortic sinuses <br>  • [[Infective endocarditis]]
| • Mild-to-moderate calcification  <br> • Rheumatic valve changes <br> •  Dilatation of aortic sinuses <br>  • [[Infective endocarditis]]
| • Mild [[AR]]:   
| • '''Mild''':   
: • Jet/LVOT <25%  
: • Jet/LVOT <25%  
: • [[Vena contracta]] <0.3 cm
: • [[Vena contracta]] <0.3 cm
Line 42: Line 42:
: • Effective regurgitant orifice <0.10 cm²
: • Effective regurgitant orifice <0.10 cm²
: • [[Aortography|Angiography]] grade 1+
: • [[Aortography|Angiography]] grade 1+
<br> • Moderate [[AR]]:
<br> • '''Moderate''':
: • Jet/LVOT: 25%–64%
: • Jet/LVOT: 25%–64%
: • [[Vena contracta]] 0.3–0.6 cm
: • [[Vena contracta]] 0.3–0.6 cm
Line 53: Line 53:


|-
|-
| style="background: #4479BA; color: #F8F8FF"|C
| style="background: #4479BA; color: #F8F8FF"|'''C'''
| Asymptomatic severe [[AR]]
| Asymptomatic severe
| • Calcific aortic valve disease  <br> • Rheumatic valve changes  <br> •  Bicuspid valve <br> •  Dilated aortic sinuses <br>  • [[Infective endocarditis]] with abnormal leaflet closure
| • Calcific aortic valve disease  <br> • Rheumatic valve changes  <br> •  Bicuspid valve <br> •  Dilated aortic sinuses <br>  • [[Infective endocarditis]] with abnormal leaflet closure
| • Severe [[AR]]
| • Severe
: • Jet/LVOT ≥65%
: • Jet/LVOT ≥65%
: • [[Vena contracta]] >0.6 cm;
: • [[Vena contracta]] >0.6 cm;
Line 64: Line 64:
: • Effective regurgitant orifice ≥0.3 cm2;
: • Effective regurgitant orifice ≥0.3 cm2;
: • [[Aortography|Angiography]]  grade 3+ to 4+;
: • [[Aortography|Angiography]]  grade 3+ to 4+;
| • C1: Normal [[LVEF]] and mild to moderate LV dilatation <br> <br>
| • '''C1:''' Normal [[LVEF]] and mild to moderate LV dilatation <br> <br>
----
----
• C2: abnormal LV systolic function with decreased LVEF or severe LV dilatation
'''C2:''' abnormal LV systolic function with decreased LVEF or severe LV dilatation
| • None <br> • Exercise testing to confirm symptom status
| • None <br> • Exercise testing to confirm symptom status


|-
|-
| style="background: #4479BA; color: #F8F8FF"|D
| style="background: #4479BA; color: #F8F8FF"|'''D'''
| Symptomatic severe [[AR]]
| Symptomatic severe [[AR]]
| • Calcific aortic valve disease  <br> • Rheumatic valve changes <br> •  Dilated aortic sinuses <br>  • [[Infective endocarditis]] with abnormal leaflet closure
| • Calcific aortic valve disease  <br> • Rheumatic valve changes <br> •  Dilated aortic sinuses <br>  • [[Infective endocarditis]] with abnormal leaflet closure
| | • Severe [[AR]]
| | • Severe
: • Jet/LVOT ≥65%
: • Jet/LVOT ≥65%
: • [[Vena contracta]] >0.6 cm;
: • [[Vena contracta]] >0.6 cm;

Revision as of 20:06, 9 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

According to the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, aortic insufficiency has 4 stages based on the valve's anatomy, hemodynamics and the patients symptoms.

Stages

Shown below is a table summarizing the stages of aortic regurgitation (AR) according to the 2014 AHA/ACC guidelines for the management of patients with valvular heart disease. [1]

Abbreviations: AR: aortic regurgitation; HF: heart failure; IE: infective endocarditis; LV: left ventricular; LVEF: left ventricular ejection fraction; LVESD: left ventricular end-systolic dimension; LVOT: left ventricular outflow tract; Jet/LVOT : jet width and LVOT ratio

STAGE DEFINITION VALVE ANATOMY VALVE HEMODYNAMICS HEMODYNAMIC CONSEQUENCES SYMPTOMS
A At risk of AR • Bicuspid valve
• Valve sclerosis
• History of rheumatic fever
Infective endocarditis
• None • None • None
B Progressive AR • Mild-to-moderate calcification
• Rheumatic valve changes
• Dilatation of aortic sinuses
Infective endocarditis
Mild:
• Jet/LVOT <25%
Vena contracta <0.3 cm
• Regurgitant volume <30 mL/beat
• Regurgitant fraction <30%
• Effective regurgitant orifice <0.10 cm²
Angiography grade 1+


Moderate:

• Jet/LVOT: 25%–64%
Vena contracta 0.3–0.6 cm
• Regurgitant volume 30–59 mL/beat
• Regurgitant fraction 30%–49%
• Effective regurgitant orifice 0.10–0.29 cm²
Angiography grade 2+
• Normal LV systolic function
• Normal LV volume or mild LV dilation
• None
C Asymptomatic severe • Calcific aortic valve disease
• Rheumatic valve changes
• Bicuspid valve
• Dilated aortic sinuses
Infective endocarditis with abnormal leaflet closure
• Severe
• Jet/LVOT ≥65%
Vena contracta >0.6 cm;
• Holodiastolic flow reversal in the proximal abdominal aorta
• Regurgitant volume ≥60 mL/beat;
• Regurgitant fraction ≥50%;
• Effective regurgitant orifice ≥0.3 cm2;
Angiography grade 3+ to 4+;
C1: Normal LVEF and mild to moderate LV dilatation


C2: abnormal LV systolic function with decreased LVEF or severe LV dilatation

• None
• Exercise testing to confirm symptom status
D Symptomatic severe AR • Calcific aortic valve disease
• Rheumatic valve changes
• Dilated aortic sinuses
Infective endocarditis with abnormal leaflet closure
• Severe
• Jet/LVOT ≥65%
Vena contracta >0.6 cm;
• Holodiastolic flow reversal in the proximal abdominal aorta
• Regurgitant volume ≥60 mL/beat;
• Regurgitant fraction ≥50%;
• Effective regurgitant orifice ≥0.3 cm2;
Angiography grade 3+ to 4+;
• May occur with normal systolic function or decreased function
• Presence of moderate to severe LV dilatation
• Exertional dyspnea
• Exertional angina
HF symptoms


References

  1. "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.

Template:WH Template:WS